Tapewire

NYSE · USD

PHR

Phreesia, Inc.

Export transactions ↓
Tapewire entity
2606
SEC CIK
0001412408
Parsed reports
753

Last 12 months

Inside the activity.

6 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 2026021
Feb 202600
Mar 202643
Apr 202625
May 202601
Jun 202601
Jul 202603
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 22, 2019 Filed Jul 24, 2019 20:16 UTC ConversionCommon Stock 3,828,872 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020231 · doc4.xml · nonDerivative · entry 1

Polaris Venture Management Co. V, L.L.C. · CIK 0001439589 · 10% owner

Polaris Venture Partners Founders' Fund V, L.P. · CIK 0001439588 · 10% owner

Polaris Venture Partners V, L.P. · CIK 0001439590 · 10% owner

Polaris Venture Partners Entrepreneurs' Fund V, L.P. · CIK 0001439587 · 10% owner

Polaris Venture Partners Special Founders' Fund V, L.P. · CIK 0001439586 · 10% owner

Flint Jonathan A · CIK 0001295676 · 10% owner

MCGUIRE TERRANCE · CIK 0001117003 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Polaris Venture Partners V, L.P.

Disclosed balance after: 3,828,872

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: Jonathan A. Flint ("Flint") and Terrance G. McGuire ("McGuire") are the managing members of Polaris Venture Management Co. V, L.L.C. ("PVM"), which is the sole general partner for each of Polaris Venture Partners V, L.P. ("PVP V"), Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVPEF V"), Polaris Venture Partners Founders' Fund V, L.P. ("PVPFF V"), and Polaris Venture Partners Special Founders' Fund V, L.P. ("PVPSF V", and together with PVP V, PVPEF V, and PVPFF V, the "Polaris Funds"). Each of Flint, McGuire, and PVM may be deemed to beneficially own the shares held by the Polaris Funds, but Flint, McGuire and PVM disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
ConversionSenior B Preferred Stock · Derivative 1,139,530 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · derivative · entry 7

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 492,424 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
ConversionSenior A Preferred Stock · Derivative 1,082,016 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · derivative · entry 6

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 518,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F3 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F3 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F3 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
ConversionJunior Convertible Preferred Stock · Derivative 4,250,111 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · derivative · entry 5

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,934,225 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
SaleCommon Stock 335,767 $18.00 $6,043,806.00
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 4

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 2,609,482

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
ConversionCommon Stock 492,424 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 3

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 2,945,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
ConversionCommon Stock 518,600 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 2

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 2,452,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
CHV II, L.P.10% owner
ConversionCommon Stock 1,934,225 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 1

CHV II, L.P. · CIK 0001615761 · 10% owner

Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By CHV II, L.P.

Disclosed balance after: 1,934,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionSenior B Preferred Stock · Derivative 113,980 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 10

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 51,872 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionSenior B Preferred Stock · Derivative 2,591,062 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 9

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 1,179,192 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F4 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionSenior A Preferred Stock · Derivative 489,756 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 8

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 222,887 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionSenior A Preferred Stock · Derivative 11,133,455 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 7

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 5,066,835 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC SaleCommon Stock 31,323 $18.00 $563,814.00
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 6

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 243,436

F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC SaleCommon Stock 712,065 $18.00 $12,817,170.00
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 5

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,533,962

F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionCommon Stock 51,872 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 4

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 274,759

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionCommon Stock 1,179,192 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 3

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 6,246,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionCommon Stock 222,887 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 2

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 222,887

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC ConversionCommon Stock 5,066,835 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 1

Perricelli Scott · CIK 0001776725 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 5,066,835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
Pegus CherylDirector
ConversionSenior B Preferred Stock · Derivative 5,410,084 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020228 · doc4.xml · derivative · entry 3

Pegus Cheryl · CIK 0001572448 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Echo Health Ventures LLC

Disclosed balance after: 0

Underlying: Common Stock · 2,462,128 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
Pegus CherylDirector
SaleCommon Stock 280,689 $18.00 $5,052,402.00
Disclosure

SEC source: 0000899243-19-020228 · doc4.xml · nonDerivative · entry 2

Pegus Cheryl · CIK 0001572448 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Echo Health Ventures LLC

Disclosed balance after: 2,181,439

F2 · ownership.nature: Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares.

Read SEC document
July 22, 2019 Filed Jul 24, 2019 20:15 UTC
Pegus CherylDirector
ConversionCommon Stock 2,462,128 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-19-020228 · doc4.xml · nonDerivative · entry 1

Pegus Cheryl · CIK 0001572448 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Echo Health Ventures LLC

Disclosed balance after: 2,462,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date.

F2 · ownership.nature: Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.